University of Miami Department of Physical Therapy
Coral Gables, Florida, 44146, United States
NCT Number: NCT01216722
Resistance strengthening exercise will increase strength and functional activity greater than ambulation in subjects post-liver transplantation.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Coral Gables, Florida, 44146, United States
Individuals post liver transplantation are significantly muscle wasted due to chronic liver disease. Current Usual care only involves progressive ambulation. Resistance exercise targeted at the lower extremities are anticipated to increase muscle strength in the muscles that extend the hip, extend the knee, and plantar flex the ankle more than seen with the usual care ambulation. The anticipated increases in strength should improve functional performance of activities such as standing from a chair, walking, and climbing stairs. The improvement in strength and functional performance should improve an individuals quality of life.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Home exercise Program. 3-4 days a week. 30 minutes a session. 12 weeks
Time frame: Baseline
Time frame: Baseline
Time frame: Baseline
Time frame: Baseline
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: Baseline
Time frame: 12 weeks
Time frame: Baseline
Time frame: 12 weeks
University of Miami
Other
Comparison of Targeted Lower Extremity Strengthening and Usual Care Progressive Ambulation in Subjects Post Liver Transplant: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07570901
Digestive System Diseases, Liver Disease (Alcoholic or Not)
Toronto, Ontario, Canada
View Trial DetailsNCT03995537
Cirrhosis, Liver, Digestive System Diseases
Lyon, France
View Trial DetailsNCT04778735
Bile Duct Diseases, Biliary Atresia
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT01046799
Blood-Borne Infections, Communicable Diseases
Essen, Germany
View Trial Details